Body mounted Laser Indirect Ophthalmoscope (LIO) system
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 12,376,994 | Body mounted Laser Indirect Ophthalmoscope (LIO) system In force · High confidence UsedRemaining | Norlase APS | In force | High confidence | ||
| Application 16/361,768 | Body mounted Laser Indirect Ophthalmoscope (LIO) system Pending Not granted | Norlase APS | Pending | Not granted | ||
| Application 19/246,755 | Body Mounted Laser Indirect Ophthalmoscope (LIO) System Pending Not granted | Norlase APS | Pending | Not granted |
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Norlase APS.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.